MedPage Today on MSN
Mixed Results With Metformin for Men on ADT for Prostate Cancer
The favorable effects observed in the study "consolidate the finding that metformin not only improves anthropometric outcomes ...
This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...
How men lose weight could affect their chances of having a baby, with new research from the University of Adelaide revealing ...
This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
New York Magazine on MSN
What a Diabetes Diagnosis Taught Me About MAHA
People develop type 2 diabetes for a combination of reasons, like a sedentary lifestyle and an unhealthy diet, but genetics ...
News-Medical.Net on MSN
Diabetes remission possible with GLP-1 drugs, Italian study confirms
In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...
Berberine is not new. Extracted from plants such as barberry, goldenseal, and tree turmeric, it has a centuries-long history ...
Women in Coweta County have a brand new option for primary care in Newnan. The Healthy Woman Primary, owned and operated by ...
Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.
An experimental GLP-1/glucagon (GCP) dual receptor agonist from Eli Lilly and its Chinese partner Innovent has bested Novo Nordisk’s reigning GLP-1 semaglutide in a phase 3 study across both b | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results